Myocardial injury and altered gene expression associated with SARS-CoV-2 infection or mRNA vaccination

NL Altman, AA Berning, CE Saxon, KE Adamek… - Basic to Translational …, 2023 - jacc.org
SARS CoV-2 enters host cells via its Spike protein moiety binding to the essential cardiac
enzyme angiotensin-converting enzyme (ACE) 2, followed by internalization. COVID-19 …

No correlation between anti-PF4 and anti–SARS-CoV-2 antibodies after ChAdOx1 nCoV-19 vaccination

G Uzun, K Althaus, T Bakchoul - New England Journal of …, 2021 - Mass Medical Soc
Pathogenic Antibodies in Patients with VITT Vaccine-induced immune thrombotic
thrombocytopenia is caused by the induction of anti-PF4 polyanion antibodies in response …

[HTML][HTML] Myocarditis after BNT162b2 and mRNA-1273 COVID-19 vaccination: A report of 7 cases

SK Ahmed - Annals of Medicine and Surgery, 2022 - Elsevier
Background and objectives According to some reports, there is a link between the
development of myocarditis and the administration of messenger RNA (mRNA) vaccines …

COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort

M Mallory, JE Munt, TM Narowski, I Castillo… - Science …, 2024 - science.org
The recommended COVID-19 booster vaccine uptake is low. At-home lateral flow assay
(LFA) antigen tests are widely accepted for detecting infection during the pandemic. Here …

Cardiac adverse events after vaccination—A Systematic Review

K Parmar, S Subramanyam, G Del Rio-Pertuz, P Sethi… - Vaccines, 2022 - mdpi.com
The Vaccine Adverse Event Reporting System database has been used to report adverse
events following several vaccines. We studied the patient population predisposed to such …

Demographic and clinical factors associated with anti–SARS-CoV-2 antibody levels after 2 BNT162b2 mRNA vaccine doses

SY Nam, SW Jeon, HS Lee, HJ Lim, DW Lee… - JAMA network …, 2022 - jamanetwork.com
Importance The factors associated with long-term serum levels of anti–SARS-CoV-2
antibodies after COVID-19 vaccination in healthy individuals have rarely been investigated …

[HTML][HTML] SARS-CoV-2 vaccines and myocarditis

AK Sularz, A Hua, T Ismail - Clinical Medicine, 2023 - Elsevier
The development of safe and effective vaccines against severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2) was a major turning point in the fight against the Coronavirus …

Targets of SARS-CoV-2: Therapeutic implications for COVID-19

R Chadha, A Raghav, B Banerjee, A Sengar, M Sengar… - Stem Cells, 2024 - Elsevier
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its
subsequent manifestation as coronavirus disease-2019 (COVID-19) marked a global health …

Effectiveness of SARS-CoV-2 vaccines for short-and long-term immunity: a general overview for the pandemic contrast

AD Inchingolo, G Malcangi, S Ceci, A Patano… - International Journal of …, 2022 - mdpi.com
Background: The recent COVID-19 pandemic produced a significant increase in cases and
an emergency state was induced worldwide. The current knowledge about the COVID-19 …

A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination

PP Piché‐Renaud, SK Morris… - British Journal of Clinical …, 2023 - Wiley Online Library
Vaccines have had a tremendous impact on reducing the burden of infectious diseases;
however, they have the potential to cause adverse events following immunization (AEFIs) …